Advancing Clinical & Diagnostic Development with AI-Powered Pathology

PathAI Logo

Sunday April 10, 2022 | 6:00 pm CST | New Orleans | In-Person Event Only

Advancing Clinical & Diagnostic Development with AI-Powered Pathology

Welcome to the PathAI Engager, an exclusive event providing pharmaceutical leaders with the chance to explore opportunities in AI-powered pathology for research and clinical development.

Spend an evening with leading experts in the field discussing best practices and examples of AI applications over a few appetizers and drinks.

This is your chance to be at the heart of the discussion by joining your peers within the translational medicine and clinical development arena to highlight how AI-powered pathology can enhance clinical opportunity and improve the delivery of precision medicine.

Expert Speakers:

Benjamin Chen

Scientific Director

Bristol Myers Squibb

Carl Barrett

Vice President, Translational Medicine


Deirdre De Steno

Vice President, BioPharma Partnerships


Eric Walk

Chief Medical Officer


Josie Hayes

Director, Head of Translational Medicine

Revolution Medicines

Planning to Stay in New Orleans? Catch Our Presentation at AACR:

Tuesday, April 12  |  3:00pm - 4:00pm

ESP21 - New advancements in AI-powered pathology and predicting gene expression and signatures from whole-slide images

Andrew H Beck

Andrew H. Beck

Co-founder & Chief Executive Officer



Restaurant August

301 Tchoupitoulas Street, New Orleans, LA, 70130

Check Out Their Website Here

Partial set round tables - August


The health, safety, and well-being of our community remain our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with New Orleans’ guidelines. For further information about Health and Safety onsite, please visit our FAQs page here.

* Please note, this is subject to change at any time without prior notice.

About PathAI

PathAI Logo

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine.